Anavex Life Sciences Corp (AVXL)

[sage4]

AVXL Calendar-  for the rest of year, gathered from  Earnings Call Transcript

- 6/18 to 6/19:  An educational presentation will be provided at the 2024 IRSF Rett Syndrome Scientific Meeting, taking place this year June 18, 2024 to June 19, 2024

- Mid-2024:   as well analysis of RNA sequencing of the trial is underway and interim data is expected by mid-2024.

2H:
- 7/25 to 7/28: the potentially pivotal ANAVEX2-73 Phase 2/3 clinical trial will be presented at the 19th National Fragile X Foundation Conference taking place in July 25, 2024 to July 28, 2024.

- the ATTENTION-AD open-label extension trial is ongoing and we expect to be able to share interim data in the second half of 2024

- PD initiation of an ANAVEX2-73 Phase 2b/3 six-month trial is expected in the second half of 2024.

- EMA Filing: Dr. M "we said we want to submit this year and we are well on track to do that. So we will provide updated timing when we get closer to the filing time. But we have very good on time with that. So stay tuned."  ".....There’s also interactions taking place with the EMA to be aligned on the technicalities,...."